At just 26, LaShae D. Rolle, MDH, CPH, received the shocking, life-altering diagnosis of HR+, HER2-, node-positive early breast cancer in October 2023. This diagnosis came with a high probability of ...

Though most breast cancers are detected by mammography before symptoms appear, common signs of breast cancer include palpable breast mass, nipple changes and regional lymphadenopathy. Breast cancer ...

Marty Willis' inspiring journey battling HER2-positive breast cancer during the pandemic highlights the importance of early ...

Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic breast cancer should know. Treatment with first-line Enhertu ...

"Therapy for small, node-negative, HER2-positive breast cancer can be challenging due to the risk of overtreatment. Our study can help assess outcomes of patients according to specific tumor sizes and ...

—Building on earlier findings, researchers sought to determine rates of neoadjuvant systemic therapy (NST) among U.S. women with cT1–2 N0 M0 HER2-positive breast cancer, plus identify factors ...

The U.S. Food and Drug Administration (FDA) has granted priority review and breakthrough therapy designation to the ...

How to navigate an early-in-life breast cancer diagnosis, from fertility concerns to career questions: What the research ...